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D1d-reactive natural killer T (NKT) cells are capable of the rapid production of both IL-4 and IFN-␥. These cells express an invariant T cell antigen receptor (TCR) ␣ chain comprised of a V␣14-J␣18 rearrangement and they recognize a nonpolymorphic class I antigen-presenting molecule, CD1d. Their response to CD1d is enhanced by the glycosphingolipid ␣-galactosylceramide (␣GalCer) (1, 2) . Because cells with this invariant V␣14 rearrangement and CD1d specificity do not always express NK1.1, we refer to these cells as V␣14 invariant (V␣14i) T cells (3) .
The results from studies of animal models of autoimmune diseases (4) (5) (6) (7) , as well as in human autoimmune disease patients (8) (9) (10) (11) , support the hypothesis that V␣14i T cells and their human homologs may regulate the immune response. They are also involved in the prevention of tumor metastases (12, 13) and in augmenting the responses to several infectious agents (14) (15) (16) . Consistent with a role in immune regulation, there is a selective decrease of IFN-␥ compared with IL-4 production after repeated doses of ␣GalCer (17) . This could be responsible for the beneficial effects of ␣GalCer treatment of diabetes-prone NOD mice and in experimental allergic encephalomyelitis models (18) (19) (20) (21) (22) . Curiously, several investigators have observed an opposite effect of ␣GalCer priming, with IFN-␥ levels increased (23) , and in a number of cases the beneficial effect of ␣GalCer depended on increased IFN-␥ rather than IL-4 (24, 25) . The reason for the apparently diverse mechanisms by which activated V␣14i T cells exert these effects is unknown; cytokine polarization of the V␣14i T cells themselves may be responsible.
To examine the potential to polarize V␣14i T cells in vivo, we analyzed both the ex vivo cytokine production by V␣14i T cells from the liver and the spleen of mice given ␣GalCer and the systemic responses of these mice by measuring the cytokines released immediately in the blood. The data reveal that V␣14i T lymphocytes are resistant to cytokine polarization in vivo, which may be related to the presence of IL-4 and IFN-␥ cytokine transcripts in these cells in the resting state.
Material and Methods
Mice and Treatments. BALB͞c, IL-12R␤2 Ϫ/Ϫ , and IL-4R␣ Ϫ/Ϫ mice on the BALB͞c background were purchased from The Jackson Laboratory. C57BL͞6 mice were offspring of stock originally obtained from The Jackson Laboratory. CD40 Ϫ/Ϫ mice on the C57BL͞6 background (26) were provided by S. Schoenberger (La Jolla Institute for Allergy and Immunology). CD28 Ϫ/Ϫ mice on the C57BL͞6 background have been described (27) . All mice were maintained under specific pathogen-free conditions. Unless otherwise indicated, mice were injected i.v. with 2 g of ␣GalCer, provided by the Pharmaceutical Research Laboratory of Kirin Brewery (Gunma, Japan). C57BL͞6 and BALB͞c mice demonstrated comparable V␣14i T cell responses to ␣GalCer, both by intracellular cytokine staining and serum cytokine levels (see Figs. 2 and 4). Miniosmotic pumps (Alzet 2001, Alza) were filled with 100 pg, 10 ng, 200 ng, or 4 g of ␣-GalCer in 0.5% polysorbate-20 and 0.9% NaCl and implanted s.c. following the manufacturer's instructions. Mice were analyzed 7 days after implantation.
Cytokine Reporter Mice. The 4get (IL-4 GFP enhanced transcript) mice have been described (28) . To generate IFN-␥ reporter mice, a fragment containing exons 2-4 and 2.5 kb of 3Ј untranslated sequence of the Ifng gene was inserted into the pgkTK vector containing the herpes simplex virus thymidine kinase gene for negative selection (29) . A bicistronic reporter cassette, containing an encephalomyocarditis virus internal ribosome entry site element, modified as described (30) , was cloned 5Ј of enhanced yellow fluorescent protein (eYFP) followed by a bovine growth hormone polyadenylation signal (CLONTECH). A loxP-flanked neomycin resistance cassette, derived from pL2neo2 (31) , was placed at the 3Ј end to generate the final cassette, which was cloned into the BamHI and SalI sites in the mutated Ifng gene. This targeting construct was electroporated into PrmCre embryonic stem cells, which express Cre recombinase under control of the protamine promoter (32) , and selection was achieved by using 400 g͞ml G418 and 2 M gancyclovir. The neomycin resistance cassette is deleted in the male germ line by Cremediated recombination. Chimeric males were bred to WT C57BL͞6 mice, and offspring were selected by using Southern blotting for the mutated knock-in Ifng allele and for deletion of the neomycin cassette. Mice were backcrossed four generations onto C57BL͞6 and used as heterozygotes. Targeted mice were designated Yeti, for yellow-enhanced transcript for IFN-␥ and will be described in more detail elsewhere (M.M., K. Mohrs, D.B.S., R. L. Reinhardt, and R.M.L., unpublished work).
Flow Cytometry and Cytokine Assays. Cells were stained with ␣GalCer͞CD1d tetramers as described (33) . mAbs used in this study for flow cytometry include FITC-, CyChrome-, or allophycocyanin (APC)-labeled anti-TCR␤ clone H57-597, phycoerythrin (PE)-or APC-labeled anti-NK1.1 clone PK136, and PE-labeled pan-NK clone DX5 (PharMingen). For intracellular staining, cells were incubated with blocking 2.4G2 anti-Fc␥R mAb and neutravidin (Molecular Probes) and then surface stained. Cells were permeabilized by using Cytofix͞Cytoperm Quantitative RT-PCR. Total RNA was extracted from sorted cells with the TRIzol solution. Reverse transcription was carried out by using the First Strand cDNA Synthesis Kit (Novagen) and oligo(dT) priming. The amount of amplicon generated during PCR was monitored by using an Applied Biosystems PRISM 5700 apparatus. A specific probe labeled with both a reporter and a quencher dye was added into the TaqMan PCR mix (Perkin-Elmer) at the beginning of the reaction. The sequences of the primers and TaqMan probes used in this study were intron-spanning and have been published (28) .
Results

Antigen Dose Does Not Influence the Pattern of Cytokine Production.
Because altering the dose of antigen can polarize naïve, conventional CD4 ϩ T cells (34, 35) , we analyzed the ability of ␣GalCer to elicit IL-4 and IFN-␥ production at different doses. The CD1d tetramer allowed us to focus on V␣14i T cells exclusively and carry out the analysis ex vivo. Consistent stimulation of a significant fraction of the V␣14i T cells required 50-200 ng of ␣GalCer. Even at the lowest stimulating dose, however, both IL-4 and IFN-␥ were detected by intracellular cytokine staining (Fig. 1) or analysis of the sera by ELISA (data not shown). At all doses that stimulated, responding lymphocytes produced both IL-4 and IFN-␥ by intracellular cytokine staining (Fig. 6 , which is published as supporting information on the PNAS web site, www.pnas.org). Another method to polarize conventional CD4 ϩ T cells is by the slow delivery of antigen by an osmotic pump placed under the skin (34, 36) . When done with ␣GalCer, tetramer ϩ cells disappeared when the highest 4-g dose was placed in the pump. Tetramer ϩ cells from mice that received lower doses, from 100 pg to 200 ng in the pumps, all produced both IL-4 and IFN-␥ after restimulation (data not shown).
V␣14i T Cells Do Not Depend on Cytokine Receptor Signaling. To investigate the dependence of V␣14i T cells on IL-4 and IL-12 for their ability to produce cytokines, we analyzed mice with mutant cytokine receptor genes. Two hours after ␣GalCer administration, intracellular cytokine staining of CD1d tetramer ϩ T cells in the liver revealed that intracellular IL-4 was not reduced in cells from the IL-4R␣ Ϫ/Ϫ mice ( Fig. 2A) . Likewise, IFN-␥ was not reduced in V␣14i T cells from IL-12R␤2 Ϫ/Ϫ mice. Similar V␣14i T cell responses were observed in the spleen (data not shown). To measure the systemic cytokine response of V␣14i T cells after ␣GalCer stimulation, we analyzed sera 2 and 6 h after injection (Fig. 2B ). Two hours after ␣GalCer injection, both the IL-4R␣ Ϫ/Ϫ and IL-12R␤2 Ϫ/Ϫ mice had serum IL-4 and IFN-␥ levels similar to that of the WT controls. By 6 h, the IL-4 levels found in all three strains were decreased. IFN-␥ levels increased markedly in the serum of WT and IL-4R␣ Ϫ/Ϫ mice by 6 h. In IL-12R␤2 Ϫ/Ϫ mice, however, serum IFN-␥ was decreased Ͼ10-fold compared with IL-4R␣ Ϫ/Ϫ or WT mice.
CD40͞CD40L interactions have been reported to be required for IFN-␥ production by cultures containing V␣14i NKT cells, whereas in the same study, CD28-B7 interactions were required for the production of both IL-4 and IFN-␥ (37). Using intracellular cytokine staining, however, we determined that virtually all CD1d͞␣GalCer tetramer ϩ cells in the liver produced both IFN-␥ and IL-4 in CD40 Ϫ/Ϫ mice 2 h after ␣GalCer administration (Fig.  2C) . Likewise, the production of IFN-␥ (Ϸ50 pg͞ml) and IL-4 in the serum at 2 h after antigen in CD40 Ϫ/Ϫ mice is similar to the levels produced by activated V␣14i T cells from WT mice. However, at 6 h, the level of IFN-␥ is much reduced (Fig. 7 , which is published as supporting information on the PNAS web site), possibly because of an inability of activated V␣14i T cells in the CD40 Ϫ/Ϫ mice to induce IL-12 production by dendritic cells or other cell types (38) . We conclude that CD40-CD40L interactions are not required for the immediate IFN-␥ production by V␣14i T cells, although, as in the IL-12R␤2 Ϫ/Ϫ mice ( Fig. 2B) , they are required for the production of systemic IFN-␥ in the serum. Similarly, V␣14i T cells from CD28 Ϫ/Ϫ mice retained the ability to produce cytokines after ␣GalCer stimulation (data not shown). Therefore, activation of V␣14i T cells and their secretion of a mixed cytokine pattern can occur in the absence of the costimulatory molecules that are important for naive T cells.
Reporter Mice Reveal Cytokine mRNAs in Resting V␣14i T Cells.
To confirm these findings, we used cytokine gene reporter mice that enable fluorescent detection of cytokine gene expression. The IL-4 reporter or 4get mice have a construct that enables IL-4 and enhanced GFP (eGFP) expression from a single bicistronic transcript. IFN-␥ reporter mice, designated Yeti, have an internal ribosome entry site-eYFP cassette immediately downstream of the IFN-␥ translation stop and upstream of the endogenous polyadenylation signal. Because the fluorescent marker proteins are trapped intracellularly, the reporter mice enable direct single-cell cytokine detection, while leaving the endogenous cytokine ORFs unmodified.
V␣14i T cells were studied in the liver and spleen of the two reporter mice before and after activation by ␣GalCer (Fig. 3) . Unexpectedly, the vast majority of V␣14i T cells in the liver and spleen of mice not exposed to ␣GalCer were eGFP ϩ in 4get mice and eYFP ϩ in Yeti mice (Fig. 3A) . Despite this finding, the IL-4 and IFN-␥ proteins were not detected by intracellular cytokine staining in unstimulated V␣14i T cells from these gene-targeted mice (data not shown) or WT mice ( Fig. 2 A and ref. 33 ). In the spleen, few conventional TCR␤ ϩ cells were eGFP ϩ (Ͻ1%) or eYFP ϩ (6%) (Fig. 3B and ref. 30) , demonstrating that the expression of the reporter genes is most prevalent in V␣14i T cells. After activation of V␣14i T cells in vivo with ␣GalCer, tetramer staining revealed evidence for TCR down-regulation, but little difference in the mean fluorescence intensities for eYFP or eGFP (Fig. 3C) . Taken together, analysis using cytokine reporter mice suggests that V␣14i T cells, in contrast to most conventional T cells, express cytokine transcripts in the resting state, but express protein only after stimulation.
Cytokine mRNA in V␣14i T Cells from WT Mice. The results from the reporter mice raised the possibility that cytokine mRNAs might be present in V␣14i T cells and revealed by the unconstrained translation of the fluorescent proteins, mediated by translation initiated from the internal ribosome entry site element. To determine whether cytokine transcripts also were present in V␣14i T cells from WT mice, we sorted V␣14i T cells from the liver and spleen of C57BL͞6 mice and performed real-time fluorogenic PCR to detect IL-4 and IFN-␥. Hypoxanthine phosphoribosyltransferase was used to normalize for differences in the amounts of starting cDNA for each sample. V␣14i T cells from the liver and spleen contained both IL-4 and IFN-␥ mRNA (Fig. 3D) . By contrast, CD4 ϩ T cells from the spleen contained Ϸ10-fold less mRNA for both IL-4 and IFN-␥. CD4 ϩ T cells from the liver did not contain IL-4 mRNA, but they did contain some IFN-␥ mRNA, although less than V␣14i T cells. This finding is perhaps consistent with the presence of activated, T helper 1 effector cells at this site.
Absence of Cytokine Polarization in Primed V␣14i T Cells. The inability to polarize cytokine production by V␣14i T cells would appear to contradict our previous reports, in which the IL-4 to IFN-␥ ratio was increased when spleen cell suspensions from mice previously primed with ␣GalCer were restimulated in vitro (17, 39) . To analyze the effect of ␣GalCer priming in vivo on subsequent V␣14i T cell responses, cytokine levels in the blood of mice reimmunized with ␣GalCer were determined by ELISA (Fig. 4A) . At 2 h, the production of IL-4 in the primed mice was reduced in proportion to the reduction in the percentage of tetramer ϩ cells found in these mice given ␣GalCer 1 week earlier (Ϸ10-fold). IFN-␥ was not detectable at 2 h after restimulation, but this finding is consistent with the low level of IFN-␥ detected in the sera of naïve mice and a proportional decrease in the tetramer ϩ cells. At 6 h after injection, however, IFN-␥ still could not be detected in the sera from the primed mice. This decrease was greater than the proportional decrease in V␣14i T cells, as a proportional 10-to 15-fold decrease below the level in the control mice still would have been nearly 10-fold above the detection limit. Therefore, primed mice re-exposed to ␣GalCer retained the ability to produce some systemic IL-4 rapidly, whereas IFN-␥ could not be detected. The T helper 2 (Th2) trend in these data are similar to the in vitro results, although in the in vitro cultures IL-4 was not decreased (17) . In these in vitro cultures, however, the dynamics of V␣14i T cell cytokine production could be altered, and furthermore, cells activated by the V␣14i T cells could have contributed to the IL-4 synthesis.
We also analyzed antigen-induced cytokine production in primed V␣14i T cells by intracellular cytokine staining. In agreement with previous results, the number of V␣14i T cells declined rapidly and became nearly undetectable within hours after ␣GalCer administration (33, 40) . This population did not recover completely within the first week after antigen priming, although more rapid recoveries have been observed in other experiments (18) . Slowed recovery of V␣14i T cells may relate to persistent antigen. Unexpectedly, however, intracellular cytokine staining of V␣14i T cells taken from primed mice reinjected with ␣GalCer showed both IFN-␥ and IL-4 (Fig. 4B) . Therefore, as in the IL-12R␤2 5, and 6 ). Between 89% and 95% of CD1d tetramer ϩ TCR␤ ϩ cells stained for intracellular IL-4 and IFN-␥. For vehicle-injected control mice and isotype control staining of ␣GalCer-injected mice, the percentage of CD1d tetramer ϩ TCR␤ ϩ cells that were positive for either IL-4 and IFN-␥ or for the isotype mAb was Ͻ3.5%. Three mice from each strain were injected. Two independent experiments were performed with similar results. (B) Serum cytokine levels. BALB͞c controls, IL-4R␣ Ϫ/Ϫ , and IL-12R␤2 Ϫ/Ϫ mice were analyzed 2 or 6 h after i.v. injection of 2 g of ␣GalCer. At 2 h, BALB͞c mice (n ϭ 6), IL-4R␣ Ϫ/Ϫ mice (n ϭ 4), and IL-12R␤2 Ϫ/Ϫ mice (n ϭ 6) were analyzed. At 6 h, BALB͞c mice (n ϭ 4), IL-4R␣ Ϫ/Ϫ mice (n ϭ 2), and IL-12R␤2 Ϫ/Ϫ mice (n ϭ 4) were analyzed. Statistical analysis was performed by using t tests to compare cytokine levels for all strains at each time point, and significant differences are indicated. * , P ϭ 0.02; ** , P ϭ 0.01. (C) Intracellular cytokine staining of liver lymphocytes 2 h after i.v. injection of 2 g of ␣GalCer in C57BL͞6 WT controls (n ϭ 2) or CD40 Ϫ/Ϫ mice (n ϭ 2). Percentage of CD1d tetramer ϩ TCR␤ ϩ cells that were positive for IL-4 and IFN-␥ ranged from 87% to 94%, whereas staining with the isotype control mAb was Ͻ5%.
This lag suggested that most of the systemic IFN-␥ in the blood might be produced by a different cell type. Previous reports have demonstrated that activated V␣14i NKT cells stimulate NK cells in an IFN-␥-dependent fashion to produce IFN-␥ (41, 42) . We therefore sought to determine whether the diminished levels of IFN-␥ in the sera of ␣GalCer-primed mice and IL-12R␤2 Ϫ/Ϫ mice were caused by a failure of NK cells to produce IFN-␥ after V␣14i T cell activation. Consistent with an earlier report (41), we found that Ϸ20-30% of the liver NK cells were positive for IFN-␥ 6 h after injection of ␣GalCer in naïve mice (Fig. 5A) . By contrast, NK cells of both ␣GalCer-primed mice and IL-12R␤2 Ϫ/Ϫ mice failed to produce detectable levels of IFN-␥. In fact, the IFN-␥ detected in the sera at this time point was similar when IL-12R␤2 Ϫ/Ϫ mice were compared with mice treated with anti-asialo GM1 before ␣GalCer injection (Fig. 5B) . This antiasialo GM1 treatment specifically depleted NK cells, but did not affect the percentage of CD1d tetramer ϩ cells (data not shown). Despite this, sorted liver NK cells from the ␣GalCer-primed mice retain the ability to make IFN-␥ in response to culture with IL-12 ( Fig. 8 , which is published as supporting information on the PNAS web site). Hence, although V␣14i T cells do not appear to be polarized by repeated exposures to ␣GalCer, or by the absence of IL-12 signaling, the systemic immune response in these mice becomes relatively Th2 polarized, which may be caused by a disruption in the V␣14i T cell-mediated activation of IFN-␥ release by NK cells.
Discussion
The role of V␣14i T cells in preventing autoimmune disease and in protective immunity has been studied extensively. The production of IFN-␥ appears to be the major mechanism for the beneficial effect of ␣GalCer stimulation of V␣14i T cells in the clearance of microbial pathogens (14, 43) and the response to tumors (25) . By contrast, the ␣GalCer-mediated stimulation of IL-4 and͞or IL-10 production underlies its beneficial effects in the prevention of several autoimmune diseases (18 -22) and the induction of anterior chamberassociated immune deviation (44) . It is not known how a single glycolipid antigen can lead to modulation of the immune response by such divergent pathways.
Our principal approach was to analyze the response immediately after activation of V␣14i T cells in vivo. Efforts to polarize V␣14i T cells by altering the dose, the route, or the timing of antigen failed to result in an alteration in the immediate cytokine production by these cells. (45) and under Th2 polarizing conditions in vitro (46) has been reported.
While this manuscript was in preparation, ex vivo analyses were reported using human V␣24i NKT cells, which are homologous to V␣14i T cells. In humans, the CD4 ϩ subset produced more IL-4 than the CD4 Ϫ subset (47, 48) , a difference that was not observed in the mouse. Results from in vitro culture of adult human V␣24i NKT cells, however, also suggested that it may be difficult to polarize cytokines in these cells (49) .
Previous reports suggested that repeated exposure to ␣GalCer favors Th2 responses (17, 39) . In our analysis, there were several instances where the intracellular cytokine staining of activated V␣14i T cells did not reflect the cytokine levels measured in the sera, including in IL-12R␤2 Ϫ/Ϫ and CD40 Ϫ/Ϫ mice. In these cases, V␣14i T cells retained the ability to produce both IL-4 and IFN-␥, although the systemic IFN-␥ decreased at 6 h after ␣GalCer stimulation. This finding correlated with decreased IFN-␥ production by NK cells from the IL-12R␤2 Ϫ/Ϫ mice, which are responsible for the bulk of the systemic IFN-␥ production after ␣GalCer activation of V␣14i NKT cells. Although it was well established that IL-12 contributes to the production of IFN-␥ after ␣GalCer injection (38, 41, 50) , here we show that IL-12-mediated signaling is required for IFN-␥ production by NK cells after V␣14i T cell activation, but not by V␣14i T cells themselves. Our data do not formally prove, however, that NK must express IL-12R␤ for the production of IFN-␥. It remains possible that the absence of IL-12R␤ on V␣14i T cells affects IFN-␥ production by NK cells in an indirect manner. Our results with the CD40 Ϫ/Ϫ mice are consistent with studies demonstrating the importance of CD40͞CD40L interactions between V␣14i T cells and dendritic cells for inducing IL-12 production by these antigen-presenting cells (51) . We suggest that the observed decrease in IFN-␥ production reported in CD40 Ϫ/Ϫ mice after in vitro activation of V␣14i T cells (37) also may be caused by a failure of NK cells in the mixed-in cultures that contained many cell types, rather than to cytokine polarization of V␣14i NKT cells. Like CD40, the NK1.1 molecule has also been proposed to bias V␣14i NKT cells to produce IFN-␥ (52) . Further studies will be required to investigate the role of other costimulatory or accessory molecules has on cytokine production by V␣14i NKT cells and their downstream effectors.
The systemic response also was Th2 polarized in mice reimmunized with ␣GalCer. The decreased production of IFN-␥ by NK cells after ␣GalCer restimulation might reflect the quantitative decrease in V␣14i T cells we observed. It remains possible, however, that qualitative changes in the V␣14i T cells, such as the predominance of relatively immature, recent thymic emigrants, is responsible. Additionally, ␣GalCer priming may cause changes in antigen-presenting cell function (53) . Our study involved repeat exposure to ␣GalCer with 1 week between initial and final exposure. More than one restimulation with ␣GalCer, or different time periods between ␣GalCer administrations, might affect the cytokine production of V␣14i NKT cells. Regardless, in all of the cases we have studied, the ability of V␣14i T cells to induce systemic IFN-␥ release correlated with their ability to activate NK cells.
We have made the intriguing observation that resting V␣14i T cells contained mRNA for both IL-4 and IFN-␥. The results from RT-PCR analysis of V␣14i T cells from WT mice corroborated the data from the cytokine gene reporter mice. Despite this, analysis of cells from WT and reporter mice for intracellular cytokines failed to detect any IL-4 or IFN-␥ protein in V␣14i T cells until they were stimulated. The presence of cytokine transcripts in resting V␣14i T cells is correlated with their immediate effector capacity, and it is likely to contribute to their rapid cytokine secretion. In addition to V␣14i T cells, other effector T cells may contain some untranslated cytokine mRNAs. Consistent with this finding, it was recently reported that memory CD8 ϩ T cells have untranslated RANTES mRNA (54) .
Our results are in contrast to those from a number of studies suggesting that V␣14i T cells behave in a more conventional manner, requiring costimulation and cytokine signaling to regulate their cytokine production (37, (55) (56) (57) . The inherent technical limitations of in vitro culture conditions may have been responsible, and in some cases some contaminating NK cells or other cell types could have secreted much of the cytokine analyzed. Additionally, the tracking and͞or isolation of V␣14i NKT cells, using for example, anti-NK1.1 in conjunction with anti-TCR␤ mAbs, does not precisely identify the ␣GalCer͞ CD1d-reactive population. Finally, sorting on the basis of NK1.1 (52) , TCR, or other markers could activate V␣14i T cells in an unphysiologic way.
Altered peptide ligands can alter the cytokine profile of conventional CD4 ϩ T cells (35) , and consistent with this, an analog of ␣GalCer with a shortened alkyl chain on the sphingosine has been reported to preferentially induce IL-4 secretion by NKT cells (58) . Much of this analysis was carried out on unfractionated spleen cells stimulated in vitro, however, and further studies will be required to determine whether this analog directly alters the quality of the response by V␣14i T cells. Finally, although V␣14i T cells contain IL-4 and IFN-␥ mRNAs, and the response of these cells in vivo could not be polarized in our studies, it remains possible that such polarized populations can be generated. If so, we speculate that this could be caused in part by posttranscriptional control of cytokine gene expression and control of transcription. Regardless, such polarized cells may have an important regulatory role that could be exploited for the generation of novel immune therapies. 
